Related Experiment Video
Updated: May 9, 2026

Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
A monoclonal antibody against human MUDENG protein
Yadav Wagley1, Jun-Ha Choi, Dimuthu Dhammika Wickramanayake
1Division of Animal Bioscience and Technology, College of Animal Bioscience and Biotechnology/Animal Resources Research Center, Konkuk University, Seoul, Korea.
Researchers developed a new antibody (M3H9) to detect the mu-2-related death-inducing gene (MuD) protein. This antibody shows potential as a biomarker for hereditary spastic paraplegia and related diseases.
Area of Science:
- Molecular Biology
- Immunology
- Neuroscience
Background:
- The mu-2-related death-inducing gene (MuD) encodes a protein involved in protein trafficking and cell death.
- MuD's role in cellular processes suggests its involvement in diseases.
Purpose of the Study:
- To generate a specific monoclonal antibody (MAb) against the human MuD protein.
- To evaluate the utility of this MAb as a potential biomarker for neurological disorders.
Main Methods:
- Generation of a mouse monoclonal antibody (M3H9, IgG sub 1) targeting residues 244-326 of the human MuD protein.
- Detection of MuD protein in astroglioma cell lines and primary astrocytes.
- Application of M3H9 MAb in enzyme-linked immunosorbent assay (ELISA) and immunoblotting.
- Immunohistochemical analysis of MuD protein in formalin-fixed, paraffin-embedded mouse tissues (ovary, uterus).
Main Results:
- The M3H9 MAb successfully recognized the MuD protein in various experimental settings.
- M3H9 MAb demonstrated efficacy in ELISA and immunoblot assays.
- The antibody detected MuD protein expression in both cell cultures and fixed tissue samples.
Conclusions:
- The M3H9 MAb is a reliable tool for detecting the MuD protein.
- MuD MAb M3H9 shows promise as a novel biomarker for hereditary spastic paraplegia and associated diseases.
- This antibody facilitates further research into MuD's function and disease relevance.
More Related Videos
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023